107 related articles for article (PubMed ID: 16601810)
1. Antiproliferative activity of berberine in vitro and in vivo.
Letasiová S; Jantová S; Múcková M; Theiszová M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Dec; 149(2):461-3. PubMed ID: 16601810
[TBL] [Abstract][Full Text] [Related]
2. Berberine-antiproliferative activity in vitro and induction of apoptosis/necrosis of the U937 and B16 cells.
Letasiová S; Jantová S; Cipák L; Múcková M
Cancer Lett; 2006 Aug; 239(2):254-62. PubMed ID: 16229943
[TBL] [Abstract][Full Text] [Related]
3. Antitumor efficiency of novel fluoro-substituted 6-amino-2-phenylbenzothiazole hydrochloride salts in vitro and in vivo.
Stojkovic R; Karminski-Zamola G; Racane L; Tralic-Kulenovic V; Glavas-Obrovac L; Ivankovic S; Radacic M
Methods Find Exp Clin Pharmacol; 2006; 28(6):347-54. PubMed ID: 16894403
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic/antiproliferative effects of new [1,2,4]triazolo[4,3-c] quinazolines in tumor cell lines HeLa and B16.
Jantová S; Letasiová S; Ovádeková R; Múcková M
Neoplasma; 2006; 53(4):291-300. PubMed ID: 16830055
[TBL] [Abstract][Full Text] [Related]
5. Different concentrations of berberine result in distinct cellular localization patterns and cell cycle effects in a melanoma cell line.
Serafim TL; Oliveira PJ; Sardao VA; Perkins E; Parke D; Holy J
Cancer Chemother Pharmacol; 2008 May; 61(6):1007-18. PubMed ID: 17661039
[TBL] [Abstract][Full Text] [Related]
6. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
[TBL] [Abstract][Full Text] [Related]
7. Berberine inhibits WEHI-3 leukemia cells in vivo.
Yu FS; Yang JS; Lin HJ; Yu CS; Tan TW; Lin YT; Lin CC; Lu HF; Chung JG
In Vivo; 2007; 21(2):407-12. PubMed ID: 17436595
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antiproliferative activity in vitro of novel (2-butynyl)thioquinolines.
Mól W; Matyja M; Filip B; Wietrzyk J; Boryczka S
Bioorg Med Chem; 2008 Sep; 16(17):8136-41. PubMed ID: 18682326
[TBL] [Abstract][Full Text] [Related]
9. Antiproliferative and antiangiogenic effects of the benzophenanthridine alkaloid sanguinarine in melanoma.
De Stefano I; Raspaglio G; Zannoni GF; Travaglia D; Prisco MG; Mosca M; Ferlini C; Scambia G; Gallo D
Biochem Pharmacol; 2009 Dec; 78(11):1374-81. PubMed ID: 19643088
[TBL] [Abstract][Full Text] [Related]
10. Berberine, a natural cholesterol reducing product, exerts antitumor cytostatic/cytotoxic effects independently from the mevalonate pathway.
Issat T; Jakóbisiak M; Golab J
Oncol Rep; 2006 Dec; 16(6):1273-6. PubMed ID: 17089049
[TBL] [Abstract][Full Text] [Related]
11. Immunomodulatory and antitumor activity of triterpenoid fractions from the rhizomes of Astilbe chinensis.
Tu J; Sun HX; Ye YP
J Ethnopharmacol; 2008 Sep; 119(2):266-71. PubMed ID: 18692123
[TBL] [Abstract][Full Text] [Related]
12. Polycyclic aromatic alkaloids. XII: In vitro- and in vivo-investigations of the cytotoxic marine alkaloid 2-bromoleptoclinidinone.
Bracher F
Pharmazie; 1997 Jan; 52(1):57-60. PubMed ID: 9035236
[TBL] [Abstract][Full Text] [Related]
13. Role of transglutaminase 2 in quercetin-induced differentiation of B16-F10 murine melanoma cells.
Forni C; Braglia R; Lentini A; Nuccetelli M; Provenzano B; Tabolacci C; Beninati S
Amino Acids; 2009 Apr; 36(4):731-8. PubMed ID: 18688565
[TBL] [Abstract][Full Text] [Related]
14. Earthworm fibrinolytic enzyme: anti-tumor activity on human hepatoma cells in vitro and in vivo.
Chen H; Takahashi S; Imamura M; Okutani E; Zhang ZG; Chayama K; Chen BA
Chin Med J (Engl); 2007 May; 120(10):898-904. PubMed ID: 17543180
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activity of Ru(III) complexes carrying beta-diketonato ligands in vitro and in vivo.
Arandjelovic SS; Bjelogrlic KS; Malesevic NN; Tesic LjZ; Radulovic SS
J BUON; 2009; 14(2):271-9. PubMed ID: 19650178
[TBL] [Abstract][Full Text] [Related]
16. Preclinical evaluation of the antineoplastic efficacy of 7-(2-hydroxyethyl)theophylline on melanoma cancer cells.
Lentini A; Tabolacci C; Nardi A; Mattioli P; Provenzano B; Beninati S
Melanoma Res; 2012 Apr; 22(2):133-9. PubMed ID: 22293828
[TBL] [Abstract][Full Text] [Related]
17. Preclinical antitumor activity of the oral platinum analog satraplatin.
Wosikowski K; Lamphere L; Unteregger G; Jung V; Kaplan F; Xu JP; Rattel B; Caligiuri M
Cancer Chemother Pharmacol; 2007 Sep; 60(4):589-600. PubMed ID: 17541592
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrially targeted effects of berberine [Natural Yellow 18, 5,6-dihydro-9,10-dimethoxybenzo(g)-1,3-benzodioxolo(5,6-a) quinolizinium] on K1735-M2 mouse melanoma cells: comparison with direct effects on isolated mitochondrial fractions.
Pereira GC; Branco AF; Matos JA; Pereira SL; Parke D; Perkins EL; Serafim TL; Sardão VA; Santos MS; Moreno AJ; Holy J; Oliveira PJ
J Pharmacol Exp Ther; 2007 Nov; 323(2):636-49. PubMed ID: 17704354
[TBL] [Abstract][Full Text] [Related]
19. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo.
Katiyar SK; Meeran SM; Katiyar N; Akhtar S
Mol Carcinog; 2009 Jan; 48(1):24-37. PubMed ID: 18459128
[TBL] [Abstract][Full Text] [Related]
20. Effect of berberine on proliferation, biosynthesis of macromolecules, cell cycle and induction of intercalation with DNA, dsDNA damage and apoptosis in Ehrlich ascites carcinoma cells.
Letasiová S; Jantová S; Miko M; Ovádeková R; Horváthová M
J Pharm Pharmacol; 2006 Feb; 58(2):263-70. PubMed ID: 16451756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
